|
NCI/FDA Memorandum of Understanding for Proteomics
|
Research Initiative
|
FDA
|
NCI
|
The purpose of this Memorandum of Understanding (MOU) is to create a framework to foster scientific and programmatic collaborations. The collaborations envisioned by this MOU involve proteomics science and technology applications such as instrument/technology validation, informatics, biological sample preparation, diagnostics, and discovery and validation of biomarkers for cancer development, therapeutics, and response. This MOU sets forth the basic principles under which the Agencies intend to work together to foster partnership in: research and education; the exchange of ideas, information, and data; the development and use of proteomics technologies that may be used by the National Cancer Institute and other sponsors in clinical applications.
|
|
Nested case-control study of lung cancer and diesel exhaust among non-metal miners
|
Research Initiative
|
CDC
|
NCI
|
A retrospective cohort mortality and nested case-control study of about 12,315 non-metal miners (278,041 person-years) to investigate risk of lung cancer in relation to quantitative measures of exposure to diesel exhaust.
|
|
Network for Improvement of Access to Treatment (NIATx)
|
Research Initiative
|
SAMHSA
|
NIDA, NIMHD
|
Research grant focused on helping drug abuse treatment organizations develop practice improvement procedures to get patients enrolled in treatment.
|
|
Neural Interfaces Conference
|
Meeting/ Workshop
|
FDA
|
NIBIB, CSR, NEI, NIA, NICHD, NIDCD, NINDS
|
The Neural Interfaces research community consists of investigators, supported by grants or contracts, who are working in areas that include functional neuromuscular/electrical stimulation, auditory prosthesis, cortical prosthesis, neuromodulation, microelectrode array technology, brain computer/machine interfaces and other related areas. Conferences were held in 2010 and 2012. Planning is underway for a conference in 2014.
|
|
Newborn Drug Development Planning Committee
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NICHD, NHLBI, NLM
|
Primary responsibility for administering, contracting, and monitoring studies to develop Investigational new drug application data for potential label modification.
|
|
Newborn Screening Coding and Terminology Guide
|
Resource Development
|
CDC, HRSA, OS
|
NLM, NHGRI, NHLBI, NICHD
|
This ongoing collaboration develops, supplements and publicizes a free online resource with guidance to help promote efficient electronic exchange of standardized newborn screening data. Related efforts include studying the screening process for diseases including severe combined immunodeficiency (SCID), lysosomal storage disorders (LSDs), and critical congenital heart disease (CCHD), and developing standard codes for ordering and reporting the results of newborn screening for SCID, CCHD, and other conditions added to the Uniform Recommended Screening Panel by the Secretary''s Advisory Committee on Heritable Disorders in Newborns and Children.
|
|
Newborn Screening Committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA
|
NICHD, NHLBI, NLM
|
The National Institutes of Health, Health Resources and Services Administration, Centers for Disease Control and Prevention (CDC), the American College of Medical Genetics and the Genetic Alliance meet monthly, in person or online, to discuss and coordinate current activities and initiatives in newborn screening. Topics include the activities of the Newborn Screening Translational Research Network Coordinating Center, the Clearinghouse of Newborn Screening Information, Sickle Cell Screening Programs, the CDC Newborn Screening Quality Assurance Program, and the Regional Newborn Screening Collaboratives.
|
|
Newborn Screening Technical Assistance and Evaluation Program (NewSTEPs) Steering Committee
|
Committee, Work group, Advisory group, or Task Force
|
HRSA
|
NICHD
|
Steering committee for the Newborn Screening Technical Assistance and Evaluation Program (NEWSteps). NEWSteps is a cooperative agreement related to newborn screening that the Health Resources and Services Administration funds.
|
|
NEXT Generation Health Study - Health Behavior in School-Age Children
|
Research Initiative
|
HRSA
|
NICHD, NHLBI, NIAAA
|
NEXT is a 7-year longitudinal assessment of a representative sample of U.S. adolescent and young adults, starting when they are in the 10th grade. The goals of the NEXT longitudinal study include: to identify the trajectory of adolescent health status and health behaviors from mid-adolescence through the post high school years; to examine individual predictors of the onset of key adolescent risk behaviors and risk indicators during this period; to identify genetic, personal, family, school, and social/environmental factors that provide or sustain positive health behaviors; to identify transition points in health risk and risk behaviors and changes in family, school, and social/environmental precursors to these transitions; and to examine the role of potential gene-environment interactions in the development of health status and health behaviors.
|
|
NHLBI Federal COPD Workshop
|
Committee, Work group, Advisory group, or Task Force
|
ACL, CDC, CMS, FDA, HRSA, IHS
|
NHLBI, NCCAM
|
The Senate Appropriations Committee in FY2012 encouraged the National Heart, Lung and Blood Institute (NHLBI) "to work with community stake-holders and other Federal Agencies, including CDC, to develop a national action plan to respond to the growing burden of this disease". In response to this congressional encouragement, NHLBI hosted in Bethesda, Maryland, on May 3, 2013, a forum of representatives from Federal Agencies and Institutes to share information about current activities related to Chronic Obstructive Pulmonary Disease (COPD) and discuss opportunities for further cooperation and enhanced effectiveness of the Federal response to this serious public health problem.
|